伪足、有氧糖酵解与肿瘤细胞迁移的研究进展

doi:10.3969/j.issn.1004-616x.2020.01.014

[1] SVITKINA T. The actin cytoskeleton and actin-based motility[J]. Cold Spring Harb Perspect Biol, 2018, 10(1):a018267.
[2] ROTTNER K, FAIX J, BOGDAN S, et al. Actin assembly mechanisms at a glance[J]. J Cell Sci, 2017, 130(20):3427-3435.
[3] JACQUEMET G, HAMIDI H, IVASKA J. Filopodia in cell adhesion, 3D migration and cancer cell invasion[J]. Curr Opin Cell Biol, 2015, 36:23-31.
[4] DOMINGUEZ R. The WH2 domain and actin nucleation:necessary but insufficient[J]. Trends Biochem Sci, 2016, 41(6):478-490.
[5] INNOCENTI M. New insights into the formation and the function of lamellipodia and ruffles in mesenchymal cell migration[J]. Cell Adh Migr, 2018, 12(5):401-416.
[6] MURPHY D A, COURTNEIDGE S A. The ‘ins’ and ‘outs’ of podosomes and invadopodia:characteristics, formation and function[J]. Nat Rev Mol Cell Biol, 2011, 12(7):413-426.
[7] EDDY R J, WEIDMANN M D, SHARMA V P, et al. Tumor cell invadopodia:invasive protrusions that orchestrate metastasis[J]. Trends Cell Biol, 2017, 27(8):595-607.
[8] RIDLEY A J. Life at the leading edge[J]. Cell, 2011, 145(7):1012-1022.
[9] SCHNOOR M, STRADAL T E, ROTTNER K. Cortactin:cell functions of A multifaceted actin-binding protein[J]. Trends Cell Biol, 2018, 28(2):79-98.
[10] WANG L L, ZHAO K, REN B C, et al. Expression of cortactin in human gliomas and its effect on migration and invasion of glioma cells[J]. Oncol Rep, 2015, 34(4):1815-1824.
[11] LIN C W, SUN M S, LIAO M Y, et al. Podocalyxin-like 1 promotes invadopodia formation and metastasis through activation of Rac1/Cdc42/cortactin signaling in breast cancer cells[J]. Carcinogenesis, 2014, 35(11):2425-2435.
[12] YAMAGUCHI H, LORENZ M, KEMPIAK S, et al. Molecular mechanisms of invadopodium formation:the role of the N-WASP-Arp2/3 complex pathway and cofilin[J]. J Cell Biol, 2005, 168(3):441-452.
[13] HUANG C L, UENO M, LIU D, et al. MRP-1/CD9 gene transduction regulates the actin cytoskeleton through the downregulation of WAVE2[J]. Oncogene, 2006, 25(49):6480-6488.
[14] VEGA F M, FRUHWIRTH G, NG T, et al. RhoA and RhoC have distinct roles in migration and invasion by acting through different targets[J]. J Cell Biol, 2011, 193(4):655-665.
[15] ITO Y, ASADA A, KOBAYASHI H, et al. Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia[J]. Mol Cell Neurosci, 2014, 61:34-45.
[16] GUO Y N, KENNEY S R, MULLER C Y, et al. R-ketorolac targets Cdc42 and Rac1 and alters ovarian cancer cell behaviors critical for invasion and metastasis[J]. Mol Cancer Ther, 2015, 14(10):2215-2227.
[17] MEHRAFROOZ B, SHAMLOO A. Mechanical differences between ATP and ADP actin states:a molecular dynamics study[J]. J Theor Biol, 2018, 448:94-103.
[18] PAVLOVA N N, THOMPSON C B. The emerging hallmarks of cancer metabolism[J]. Cell Metab, 2016, 23(1):27-47.
[19] ANCEY P B, CONTAT C, MEYLAN E. Glucose transporters in cancer-from tumor cells to the tumor microenvironment[J]. FEBS J, 2018, 285(16):2926-2943.
[20] YEUNG S J, PAN J, LEE M H. Roles of p53, MYC and HIF-1 in regulating glycolysis-the seventh hallmark of cancer[J]. Cell Mol Life Sci, 2008, 65(24):3981-3999.
[21] COURTNAY R, NGO D C, MALIK N, et al. Cancer metabolism and the Warburg effect:the role of HIF-1 and PI3K[J]. Mol Biol Rep, 2015, 42(4):841-851.
[22] STINE Z E, WALTON Z E, ALTMAN B J, et al. MYC, metabolism, and cancer[J]. Cancer Discov, 2015, 5(10):1024-1039.
[23] ZHAO M T, ZHANG Z Y. Glucose transporter regulation in cancer:a profile and the loops[J]. Crit Rev Eukaryot Gene Expr, 2016, 26(3):223-238.
[24] WANG L Y, LIU Y P, CHEN L G, et al. Pyruvate kinase M2 plays a dual role on regulation of the EGF/EGFR signaling via E-cadherin-dependent manner in gastric cancer cells[J]. PLoS One, 2013, 8(6):e67542.
[25] ZHOU C F, LI X B, SUN H, et al. Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells[J]. IUBMB Life, 2012, 64(9):775-782.
[26] BAUMANN F, LEUKEL P, DOERFELT A, et al. Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2[J]. Neuro-Oncology, 2009, 11(4):368-380.
[27] SHIRAISHI T, VERDONE J E, HUANG J, et al. Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells[J]. Oncotarget, 2015, 6(1):130-143.
[28] DE BOCK K, GEORGIADOU M, SCHOORS S, et al. Role of PFKFB3-driven glycolysis in vessel sprouting[J]. Cell, 2013, 154(3):651-663.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	ZHAO Yan, SUN Zhenxiao. Metformin inhibitd proliferation and migration of human breast cancer cell in vitro [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(1): 35-39.
[2]	. [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(1): 72-74.
[3]	WANG Miao, WANG Quankai, LI Xinwei, MA Shunpeng, WUHAN Baolier, XU Jianning. m⁶A methylation of mRNAs in glycidyl methacrylate-induced malignant transformation of 16HBE cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 405-409.
[4]	LIU Ning, LIANG Lanlan, LI Shufang, SHEN Xiangchun, LIANG Bing. Anti-tumor effects of oxymatrine on mouse sarcoma and live cancers in vivo and in vitro [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 426-429,434.
[5]	GAO Xiaobin, WU Xueliang, WANG Shengjie, SUN Guangyuan, WANG Wenjing, LIANG Feng, ZHAO Yifeng, LIU Zhenxian, ZHANG Yingchun. Expression of TRIM59 and its correlations with clinicopathological features in colorectal cancers [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 446-450.
[6]	. [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 470-474.
[7]	. [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 475-481.
[8]	ZHANG Zongming. Does thyroid microcarcinoma require surgery [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(5): 325-326.
[9]	CHENG Shujun. Aging and malignant tumor─Thought on prevention and control [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 161-162.
[10]	ZHANG Die, LIU Xianghe, HUO Miaomiao, LIU Mei, XU Ningzhi, ZHU Hongxia. Effects of miR-195-5p on radiosensitivity of esophageal squamous cell carcinoma cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(2): 81-88,94.
[11]	CUI Zhaoyang, LI Suna, JIANG Xuqian, WANG Yidan, HOU Liying. Activation of the TRAIL death receptor by apigenin for induction of apoptosis in the gastric cancer SGC-7901 cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(1): 32-36.
[12]	. [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(1): 66-71,76.
[13]	. [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(1): 72-76.
[14]	LI Jinglei, HOU Wei. ceRNA network-based stigmasterolintervention on lung squamous cell carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 423-429.
[15]	SHI Hailin, HE Tianji, LIU Feng, CAI Menghui, GE Bo. Prognostic value of TCGA-database mutation burden in muscle-invasive bladder cancers [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 430-437,443.